Skip to main content
. 2017 Apr 4;8(20):33586–33600. doi: 10.18632/oncotarget.16829

Table 4. Univariate and multivariate analysis of prognostic parameters for survival in patients with CRC.

Prognostic parameter Univariable analysis Multivariable analysis
HR (95% CI) P value HR (95% CI) P value
Expression of NOX4 (high vs. low) 3.342 (1.679–6.652) 0.001* 2.919 (1.382–6.163) 0.005*
Age (< 65 vs. ≥ 65) 1.186 (0.643–2.186) 0.585
Sex (male vs. female) 1.310 (0.702–2.443) 0.396
Tumor location (right hemicolon vs. left hemicolon) 0.862 (0.472–1.574) 0.629
Tumor size (< 5 cm vs. ≥ 5 cm) 2.218 (1.155–4.259) 0.017* 2.158 (1.101–4.231) 0.025*
T classification (T1 vs. T2 vs. T3 vs. T4) 1.723 (1.007–2.949) 0.047* 0.967 (0.562–1.663) 0.903
Lymph node metastasis (Absent vs. Present) 1.707 (0.931–3.130) 0.084
Distant metastasis (Absent vs. Present) 5.269 (2.307–12.033) 0.000* 3.209 (1.321–7.799) 0.010*
Tumor differentiation (Well/moderate vs. poor) 1.475 (0.769–2.831) 0.242

The bold number indicates the P-values with statistical significance. HR: Hazard ratio; CI: Confidence interval.